Argent Biopharma Ltd (RGT.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | |
| Sales | 352 | 334 | N/A | N/A |
| Gross Profit | 352 | 334 | N/A | N/A |
| Operating Expenses | 4,054 | 3,638 | 3,557 | 2,895 |
| Operating Income | -3,702 | -3,304 | -3,557 | -2,895 |
| Interest Expense | 1,737 | 574 | 11 | 26 |
| Other Income | 2,259 | 1,932 | 1,942 | 2,839 |
| Pre-tax Income | -3,180 | -1,946 | -1,625 | -82 |
| Income Tax | 0 | 0 | 252 | 0 |
| Net Income Continuous | -3,180 | -1,946 | -1,877 | -82 |
| Minority Interests | 549 | N/A | N/A | N/A |
| Net Income | $-2,631 | $-1,946 | $-1,877 | $-82 |
| EPS Basic Total Ops | -326.13 | -244.60 | -235.86 | -11.07 |
| EPS Basic Continuous Ops | -326.13 | -244.60 | -235.86 | -11.07 |
| EPS Diluted Total Ops | -326.13 | -244.60 | -235.86 | -11.07 |
| EPS Diluted Continuous Ops | -326.13 | -244.60 | -235.86 | -11.07 |
| EBITDA(a) | $-1,406 | $-1,337 | $-1,567 | $-15 |